We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$665M
AUM Growth
+$25.6M
(+4%)
Cap. Flow
-$52.2M
Cap. Flow
% of AUM
-7.86%
Top 10 Holdings %
Top 10 Hldgs %
7.74%
Holding
429
New
135
Increased
44
Reduced
92
Closed
135
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CEVA Inc
CEVA
|
+$3.56M |
| 2 |
SN
Sanchez Energy Corporation
SN
|
+$3.52M |
| 3 |
Amphastar Pharmaceuticals
AMPH
|
+$3.48M |
| 4 |
Supernus Pharmaceuticals
SUPN
|
+$3.34M |
| 5 |
Onto Innovation
ONTO
|
+$3.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck India Growth Leaders ETF
GLIN
|
+$7.84M |
| 2 |
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
|
+$6.06M |
| 3 |
NPTN
NEOPHOTONICS CORP
NPTN
|
+$4.84M |
| 4 |
John B. Sanfilippo & Son
JBSS
|
+$4.26M |
| 5 |
PFSW
PFSweb, Inc.
PFSW
|
+$4.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.23% |
| 2 | Healthcare | 17.41% |
| 3 | Industrials | 16.86% |
| 4 | Consumer Discretionary | 12.67% |
| 5 | Materials | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
FIVE9
FIVN
$1.77B
| $8.53M | 1.28% |
716,979
+4,118
| +0.6% | +$41.8K |
|
2
MGP Ingredients
MGPI
$380M
| $6.27M | 0.94% |
163,999
+84,838
| +107% | +$2.52M |
|
3
NeoGenomics
NEO
$1.86B
| $5.57M | 0.84% |
693,010
-107,181
| -13% | -$859K |
|
4
Mitek Systems
MITK
$772M
| $4.63M | 0.7% |
651,277
+178,471
| +38% | +$1.33M |
|
|
LOXO
5
DELISTED
Loxo Oncology, Inc
LOXO
| $4.63M | 0.7% |
199,730
-15,129
| -7% | -$377K |
|
|
USCR
6
DELISTED
U S Concrete, Inc.
USCR
| $4.53M | 0.68% |
74,422
-30,632
| -29% | -$1.92M |
|
7
Exelixis
EXEL
$14B
| $4.38M | 0.66% |
560,317
+376,427
| +205% | +$2.17M |
|
8
Caesars Entertainment
CZR
$6.09B
| $4.36M | 0.66% |
286,730
-38,314
| -12% | -$524K |
|
9
Astec Industries
ASTE
$1.31B
| $4.28M | 0.64% |
76,193
+1,053
| +1% | +$53.5K |
|
10
TherapeuticsMD
TXMD
$24.2M
| $4.27M | 0.64% |
10,056
-114
| -1% | -$47K |
|
11
Coeur Mining
CDE
$15.9B
| $4.21M | 0.63% |
+394,887
| New | +$3.1M |
|
12
Universal Electronics
UEIC
$58.1M
| $4.18M | 0.63% |
57,836
+509
| +0.9% | +$33.4K |
|
13
Agree Realty
ADC
$9.69B
| $4.03M | 0.61% |
83,435
+57,226
| +218% | +$2.41M |
|
|
14
Amphastar Pharmaceuticals
AMPH
$827M
| $3.98M | 0.6% |
+246,805
| New | +$3.48M |
|
15
Evolent Health
EVH
$493M
| $3.97M | 0.6% |
+206,806
| New | +$2.84M |
|
|
VASC
16
DELISTED
Vascular Solutions Inc
VASC
| $3.94M | 0.59% |
94,505
+60,782
| +180% | +$2.26M |
|
17
8x8 Inc
EGHT
$251M
| $3.9M | 0.59% |
267,271
+3,999
| +2% | +$49K |
|
|
IPHI
18
DELISTED
INPHI CORPORATION
IPHI
| $3.9M | 0.59% |
121,687
-14,549
| -11% | -$456K |
|
|
19
Onto Innovation
ONTO
$14.1B
| $3.86M | 0.58% |
+185,816
| New | +$3.28M |
|
20
Gibraltar Industries
ROCK
$1.35B
| $3.85M | 0.58% |
122,031
-20,727
| -15% | -$597K |
|
|
GIMO
21
DELISTED
Gigamon Inc.
GIMO
| $3.84M | 0.58% |
102,583
+59,108
| +136% | +$1.88M |
|
|
22
Supernus Pharmaceuticals
SUPN
$2.69B
| $3.83M | 0.58% |
+188,277
| New | +$3.34M |
|
|
23
CEVA Inc
CEVA
$1.04B
| $3.83M | 0.58% |
+140,892
| New | +$3.56M |
|
|
SUP
24
DELISTED
Superior Industries International
SUP
| $3.83M | 0.58% |
142,931
+107,140
| +299% | +$2.75M |
|
25
Duluth Holdings
DLTH
$160M
| $3.82M | 0.57% |
156,087
+105,396
| +208% | +$2.48M |
|
Similar funds
NEPWA
RWM
MCM
HP
OMG
RB
BGC
ICCFIA
EAM Investors's Q2 2016 Portfolio in Review
As of Q2 2016, EAM Investors held 429 positions worth $665M, up 4% from $639M the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.
EAM Investors withdrew a net $52.2M in Q2 2016, closing 135 positions and reducing 92 holdings. Its most notable exit was CELATOR PHARMACEUTICALS INC. COMMON STOCK, an estimated $6.06M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, EAM Investors opened a new position in CEVA Inc worth $3.83M.
- EAM Investors's largest Q2 2016 buy was CEVA Inc: 140,892 shares worth $3.83M.
- EAM Investors added most to Superior Industries International in Q2 2016, an estimated $2.75M increase.
- EAM Investors's biggest Q2 2016 reduction was VanEck India Growth Leaders ETF, cutting an estimated $7.84M.
- EAM Investors fully exited CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016, selling an estimated $6.06M.
- EAM Investors's ten largest holdings make up 7.7% of its $665M portfolio in Q2 2016.
- EAM Investors opened 135 new positions and closed 135 in Q2 2016.
- EAM Investors's portfolio value rose 4% quarter-over-quarter to $665M.
Based on EAM Investors's 13F filing for Q2 2016, filed 4 Aug 2016.